City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Amrita Y. Krishnan, MD  
Search results:  6  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-6 Trials Jump to page:

COH Protocol Number: 14156 ClinicalTrials.gov Number: NCT02223598

Principal Investigator: Amrita Krishnan, MD
Sponsor: Industrial

Title:  A Phase 1, Dose-Escalation /Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Orally Administered CB-5083 in Patients with Relapsed/Refractory Multiple Myeloma

COH Protocol Number: 14098

Principal Investigator: Amrita Krishnan, MD
Sponsor: Institutional

Title:  Plasma Cell Malignancy Tissue Collection Study

COH Protocol Number: 13282 ClinicalTrials.gov Number: NCT01961063

Principal Investigator: Amrita Krishnan, MD
Sponsor: Institutional

Title:  Safety and Feasibility of Gene Transfer After Frontline Chemotherapy for Non-Hodgkin Lymphoma in AIDS Patients Using Peripheral Blood Stem/Progenitor Cells Treated with a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs

COH Protocol Number: 12267 ClinicalTrials.gov Number: NCT02119468

Principal Investigator: Amrita Krishnan, MD
Sponsor: Institutional

Title:  Phase I/II Trial of MLN9708 plus Pomalidomide and Dexamethasone for Relapsed or Relapsed Refractory Multiple Myeloma

COH Protocol Number: 08102 ClinicalTrials.gov Number: NCT00628498

Principal Investigator: Amrita Krishnan, MD
Sponsor: Industrial

Title:  Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study(Under CFR 312.34)

COH Protocol Number: 07076 ClinicalTrials.gov Number: NCT00695409

Principal Investigator: Amrita Krishnan, MD
Sponsor: NCI Approved External Peer Review

Title:  A Phase II Study of Yttrium-90-Labeled Anti-CD20 Monoclonal Antibody in Combination with High-Dose Beam (BCNU, Etoposide, Cytarabine and Melphalan) Followed by Autologous Stem Cell Transplantation for Patients with Poor Risk/Relapsed B-Cell Lymphoma

 
Results per page: 25 50 100 All 1-6 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.